Satheesh B. Ravula
12Patents
2h-index
18Co-inventors
47Inventor score
Filing activity: May 24, 2011 → Dec 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8846909B2 | Bicyclic heteroaryl kinase inhibitors and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10227333B2 | Inhibition of OLIG2 activity | Chemistry; Metallurgy | 3 | Active |
| US10570103B2 | Heterocyclic compounds useful in the treatment of disease | Chemistry; Metallurgy | 2 | Active |
| US11427552B2 | Heterocyclic compounds useful in the treatment of disease | Chemistry; Metallurgy | 0 | Active |
| US11712418B2 | Chemoembolization agents | Human Necessities | 0 | Active |
| US10526298B2 | Heterocyclic compounds useful in the treatment of disease | Chemistry; Metallurgy | 0 | Active |
| US11866421B2 | Pyrimidine and pyridine amine compounds and usage thereof in disease treatment | Chemistry; Metallurgy | 0 | Active |
| US11691951B2 | Inhibition of Olig2 activity | Chemistry; Metallurgy | 0 | Active |
| US9370515B2 | Mixed lineage kinase inhibitors and method of treatments | Emerging Cross-Sectional Technologies | 0 | Active |
| US10000459B2 | Heterocyclic compounds useful in the treatment of disease | Chemistry; Metallurgy | 0 | Active |
| US12234224B2 | Pyrimidine and pyridine amine compounds and usage thereof in disease treatment | Chemistry; Metallurgy | 0 | Active |
| US12357570B2 | Chemoembolization agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.